Skip to main content

Main menu

  • Home
  • Content
    • Current Issue
    • Ahead of Print
    • Past Issues
    • Supplements
    • Article Type
  • Specialty
    • Articles by Specialty
  • CME/MOC
    • Articles
    • Calendar
  • Info For
    • Manuscript Submission
    • Authors & Reviewers
    • Subscriptions
    • About CCJM
    • Contact Us
    • Media Kit
  • Conversations with Leaders
  • Conference Coverage
    • Kidney Week 2024
    • CHEST 2024
    • ACR Convergence 2023
    • Kidney Week 2023
    • ObesityWeek 2023
    • IDWeek 2023
    • CHEST 2023
    • MDS 2023
    • IAS 2023
    • ACP 2023
    • AAN 2023
    • ACC / WCC 2023
    • AAAAI Meeting 2023
    • ACR Convergence 2022
    • Kidney Week 2022
    • AIDS 2022
  • Other Publications
    • www.clevelandclinic.org

User menu

  • Register
  • Log in

Search

  • Advanced search
Cleveland Clinic Journal of Medicine
  • Other Publications
    • www.clevelandclinic.org
  • Register
  • Log in
Cleveland Clinic Journal of Medicine

Advanced Search

  • Home
  • Content
    • Current Issue
    • Ahead of Print
    • Past Issues
    • Supplements
    • Article Type
  • Specialty
    • Articles by Specialty
  • CME/MOC
    • Articles
    • Calendar
  • Info For
    • Manuscript Submission
    • Authors & Reviewers
    • Subscriptions
    • About CCJM
    • Contact Us
    • Media Kit
  • Conversations with Leaders
  • Conference Coverage
    • Kidney Week 2024
    • CHEST 2024
    • ACR Convergence 2023
    • Kidney Week 2023
    • ObesityWeek 2023
    • IDWeek 2023
    • CHEST 2023
    • MDS 2023
    • IAS 2023
    • ACP 2023
    • AAN 2023
    • ACC / WCC 2023
    • AAAAI Meeting 2023
    • ACR Convergence 2022
    • Kidney Week 2022
    • AIDS 2022

More articles from Current Drug Therapy

  • You have access
    Stress ulcer prophylaxis: The case for a selective approach
    Mary Beth Bobek, PharmD and Alejandro C. Arroliga, MD
    Cleveland Clinic Journal of Medicine November 1997, 64 (10) 533-542;

    Although stress-related mucosal damage is common in critically ill patients, the risk of significant gastrointestinal bleeding appears to be confined to patients with certain risk factors. A full-color illustration explaining the pathogenesis of stress-related mucosal damage accompanies this article.

  • You have access
    New drugs for reducing cardiovascular risk in women
    Holly L. Thacker, MD and Hussein Saadi, MD
    Cleveland Clinic Journal of Medicine October 1997, 64 (9) 493-502;

    Strategies to reduce cardiovascular risk in women, focusing on new drugs to treat diabetes and hyperlipidemia.

  • You have access
    Carvedilol for heart failure: Renewed interest in beta blockers
    James B. Young, MD
    Cleveland Clinic Journal of Medicine September 1997, 64 (8) 415-422;

    The idea of using beta blockers to treat heart failure seems counterintuitive. But Carvedilol is changing that thinking.

  • You have access
    How physicians can prevent medication errors: practical strategies
    Edward H. Jones, PharmD and Rex Speerhas, RPH
    Cleveland Clinic Journal of Medicine July 1997, 64 (7) 355-359;

    Until improved systems are in place to detect and analyze medication errors, physicians can prevent many serious medication errors by observing some basic safety practices.

  • You have access
    Cosmetic use of alpha-hydroxy acids
    Wilma F. Bergfeld, MD
    Cleveland Clinic Journal of Medicine June 1997, 64 (6) 327-329;

    Alpha-hydroxy acids exfoliate dead skin cells, moisturize the skin, and possibly rejuvenate skin damaged by photoaging.

  • You have access
    Troglitazone: a new antihyperglycemic agent
    Rex A. Speerhas, RPH and S. Sethu K. Reddy, MD, FRCPC
    Cleveland Clinic Journal of Medicine May 1997, 64 (5) 238-240;

    Indications for and use of the newest oral drug for the treatment of type II diabetes.

  • You have access
    The role of azole antifungal agents for systemic antifungal therapy
    Yu-Ping Lee, PharmD and Morton Goldman, PharmD
    Cleveland Clinic Journal of Medicine February 1997, 64 (2) 99-106;

    The azoles have not supplanted amphotericin B for managing most serious fungal infections, hut they offer alternatives in a variety of unique situations.

  • You have access
    New antidepressants: more options for tailoring treatment
    David J. Muzina, MD and Donald A. Malone, MD
    Cleveland Clinic Journal of Medicine November 1996, 63 (7) 406-412;

    The newer antidepressants cause fewer, less severe side effects than older drugs. Differing mechanisms of action of these new agents offer additional options for tailoring treatment to individual patients.

  • You have access
    Current issues in menopausal hormone replacement therapy
    Holly L. Thacker, MD
    Cleveland Clinic Journal of Medicine October 1996, 63 (6) 344-353;

    For most menopausal women, the benefits of hormone replacement therapy out-weigh the risks, despite the fears aroused by an unproven link to breast cancer.

  • You have access
    Conscious sedation: what an internist needs to know
    Thomas L. Higgins, MD, Charles J. Hearn, DO and Walter G. Maurer, MD
    Cleveland Clinic Journal of Medicine October 1996, 63 (6) 355-361;

    The use of conscious sedation rather than general anesthesia is increasing in the shift to outpatient care, but the technique poses its own special dangers.

Pages

  • Previous
  • Next
  • 1
  • …
  • 5
  • 6
  • 7
  • 8
  • 9
  • 10
  • 11
  • 12
  • 13
  • …
  • 14

Navigate

  • Current Issue
  • Past Issues
  • Supplements
  • Article Type
  • Specialty
  • CME/MOC Articles
  • CME/MOC Calendar
  • Media Kit

Authors & Reviewers

  • Manuscript Submission
  • Authors & Reviewers
  • Subscriptions
  • About CCJM
  • Contact Us
  • Cleveland Clinic Center for Continuing Education
  • Consult QD

Share your suggestions!

Copyright © 2025 The Cleveland Clinic Foundation. All rights reserved. The information provided is for educational purposes only. Use of this website is subject to the website terms of use and privacy policy. 

Powered by HighWire